Themes
Century secures $60m in stock sale and buys preclinical cell therapy biotech
Century will pay $35m upfront and an additional $10m milestone payments to acquire Clade Therapeutics.
Bayer and Google Cloud to develop AI solutions for radiologists
Pluri launches manufacturing division as cell therapy pipeline progresses
J&J and Legend’s Carvykti scores early line approval for MM by FDA
Q&A: BARDA wants to back tech that can combat multiple infections, says director
Can pharma overcome generative AI’s bias problem?
